LCAT deficiency is reported to contribute to diminished HDL cholesterol content and impaired HDL maturation in advanced CKD patients, which further increases oxidative stress and cardiovascular mortality in patients with CKD (Moradi et al., 2009; Ribeiro et al., 2012). This evidence concerns the gene LCAT and chronic kidney disease.